Fiche centre
Instituto Nacional de Neurologia y Neurocirugia
Mexico City — Mexico
Essais liés3clinical trials
VilleMexico Citylocalisation
PaysMexicolocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05142085
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Efficacy of Nano-PSO in Parkinson's Disease. | Parkinson | Non applicable | NCT05142085 | Efficacy of Nano-PSO in Parkinson's Disease. | UNKNOWN |
| Prasinezumab | Parkinson | Phase 3 | NCT07174310 | PARAISO — A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease | RECRUITING |
| Ocrelizumab | SEP | Phase 3 | NCT01194570 | ORATORIO — A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis | COMPLETED |